<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Interv Aging</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Interv Aging</journal-id>
      <journal-title-group>
        <journal-title>Clinical Interventions in Aging</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1176-9092</issn>
      <issn pub-type="epub">1178-1998</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24368882</article-id>
      <article-id pub-id-type="pmc">3869913</article-id>
      <article-id pub-id-type="doi">10.2147/CIA.S51640</article-id>
      <article-id pub-id-type="publisher-id">cia-9-031</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case of atypical progressive supranuclear palsy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Spaccavento</surname>
            <given-names>Simona</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cia-9-031"/>
          <xref ref-type="corresp" rid="c1-cia-9-031"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Del Prete</surname>
            <given-names>Marina</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cia-9-031"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Craca</surname>
            <given-names>Angela</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cia-9-031"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Loverre</surname>
            <given-names>Anna</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cia-9-031"/>
        </contrib>
      </contrib-group>
      <aff id="af1-cia-9-031">IRCCS Salvatore Maugeri Foundation, Cassano Murge, Bari, Italy</aff>
      <author-notes>
        <corresp id="c1-cia-9-031">Correspondence: Simona Spaccavento, IRCCS Salvatore Maugeri Foundation; Via per Mercadante Km 2, 70020 Cassano Murge, Bari, Italy, Tel +39 080 781 4261, Fax +39 080 781 4310, Email <email>simona.spaccavento@fsm.it</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <volume>9</volume>
      <fpage>31</fpage>
      <lpage>39</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2014 Spaccavento et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution &#x2014; Non Commercial (unported, v3.0) License</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license>
          <license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Progressive supranuclear palsy (PSP) is a neurodegenerative extrapyramidal syndrome. Studies have demonstrated that PSP can present clinically as an atypical dementing syndrome dominated by a progressive apraxia of speech (AOS) and aphasia.</p>
        </sec>
        <sec>
          <title>Aim</title>
          <p>We aimed to investigate the clinical presentation of PSP, using a comprehensive multidimensional evaluation, and the disease response to various pharmacological treatments.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>A 72-year-old right-handed male, with 17 years education, who first presented with aphasia, AOS, depression, apathy, and postural instability at 69 years; a complete neuropsychological evaluation, tapping the different cognitive domains, was performed.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Testing revealed a moderate global cognitive deficit (Mini-Mental State Examination test score =20), low memory test scores (story recall, Rey&#x2019;s 15-word Immediate and Delayed Recall), and poor phonemic and semantic fluency. The patient&#x2019;s language was characterized by AOS, with slow speech rate, prolonged intervals between syllables and words, decreased articulatory accuracy, sound distortions, and anomia. Behavioral changes, such as depression, anxiety, apathy, and irritability, were reported. The neurological examination revealed supranuclear vertical gaze palsy, poor face miming, and a mild balance deficit. Magnetic resonance imaging showed only widespread cortical atrophy. Single photon emission computed tomography demonstrated left &gt; right frontotemporal cortical abnormalities. After 6 months, a further neuropsychological assessment showed a progression in cognitive deficits, with additional attention deficits. The patient reported frequent falls, but the neurological deficits remained unchanged. Neuroimaging tests showed the same brain involvement.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Our case highlights the heterogeneity of the clinical features in this syndrome, demonstrating that atypical PSP can present as AOS and aphasia, without the classical features or involvement of the subcortical gray and brainstem region, commonly affected in typical PSP.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>pharmacological treatments</kwd>
        <kwd>neuropsychological deficits</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Progressive supranuclear palsy (PSP) is a neurodegenerative extrapyramidal syndrome, characterized by motor symptoms, such as postural instability, rigidity, akinesia, and behavioral and cognitive symptoms. The disease is progressive, and patients have a median survival of around 6 years after onset of symptomatology, which usually occurs between 55 and 70 years of age. Both sexes are nearly equally affected, with an annual incidence of 5.3 per 100,000 inhabitants in Europe.<xref rid="b1-cia-9-031" ref-type="bibr">1</xref>&#x2013;<xref rid="b3-cia-9-031" ref-type="bibr">3</xref> The most common problem of PSP is postural instability and frequent falls, followed by dysarthria as the second most common symptom, and bradykinesia as the third. Visual disturbances are also early symptoms. Supranuclear gaze deficits involve either downward or upward gaze and later, horizontal gaze.<xref rid="b4-cia-9-031" ref-type="bibr">4</xref></p>
      <p>The pathological changes are characterized by neuronal loss, with gliosis and neurofibrillary tangles in the subcortical and brainstem nuclei and the cerebellar dentate nucleus.<xref rid="b5-cia-9-031" ref-type="bibr">5</xref></p>
      <p>As regards the neuropsychological features, many cases of PSP with subcortical dementia have been described in literature.<xref rid="b6-cia-9-031" ref-type="bibr">6</xref>,<xref rid="b7-cia-9-031" ref-type="bibr">7</xref> Patients typically have cognitive deficits in executive functions, attention, and memory.<xref rid="b8-cia-9-031" ref-type="bibr">8</xref>,<xref rid="b9-cia-9-031" ref-type="bibr">9</xref> General slowness of information processing, deficits in focused and divided attention and reduced verbal fluency are all characteristics related to impaired frontal-executive functions. However, many studies have also shown the involvement of other aspects of cognition, such as language and visuospatial skills.<xref rid="b8-cia-9-031" ref-type="bibr">8</xref>,<xref rid="b10-cia-9-031" ref-type="bibr">10</xref>,<xref rid="b11-cia-9-031" ref-type="bibr">11</xref> Nonfluent aphasia and progressive apraxia of speech (AOS) can characterize the clinical symptomatology of PSP, as recently described in repeated studies.<xref rid="b12-cia-9-031" ref-type="bibr">12</xref>&#x2013;<xref rid="b14-cia-9-031" ref-type="bibr">14</xref></p>
      <p>As to the neuropsychiatric aspects, apathy has been described as the most frequent behavioral abnormality in these patients, followed by disinhibition, and depression.<xref rid="b15-cia-9-031" ref-type="bibr">15</xref> These symptoms appear in the early stages of the disease, advancing independently with disease duration, and are mediated by abnormalities of the frontal lobe or frontal&#x2013;subcortical connections.</p>
      <p>The alterations of the neurotransmitter system in PSP mainly involve the dopaminergic and cholinergic systems.<xref rid="b16-cia-9-031" ref-type="bibr">16</xref> Degeneration of the dopaminergic system could be related to some of the parkinsonian symptoms seen with PSP, whereas the cholinergic deficits seem to be associated with cognitive impairment. Also, the &#x3B3;-aminobutyric acid (GABA)ergic system may be involved in the pathogenesis of PSP.<xref rid="b5-cia-9-031" ref-type="bibr">5</xref></p>
      <p>The aim of this paper was to present the case of a patient with atypical PSP, presenting aphasia and AOS without the classical involvement of either the subcortical gray or brainstem region. We focused both on the neuropsychological profile and on the response of the disease to the various pharmacological treatments.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec>
        <title>Case description</title>
        <p>The patient was a 72-year-old, right-handed male, with 17 years of education and no family history of a neurodegenerative disorder. He was a retired university office manager. The patient only suffered from high blood pressure and was in good health until approximately 2 years before presentation, when he was affected by a depression of mood state.</p>
        <p>A neuropsychological evaluation performed at that time, in 2009, highlighted only an impairment in episodic memory and reduced phonemic fluency and a pathological performance in the Frontal Assessment Battery.<xref rid="b17-cia-9-031" ref-type="bibr">17</xref></p>
        <p>At the first visit in our clinic, in January 2011, a general physical examination did not reveal any known pathology. A neurological examination detected hypomimic facies; impaired balance; ataxic-type gait; pyramidal-extrapyramidal hypertonia in all four limbs; reduced strength, especially on the right side; wide-base standing position; and supranuclear upgaze paresis.</p>
        <p>Magnetic resonance imaging (MRI) showed the ventricular&#x2013;cisternal system in its normal axis, normal morphology and size, and no areas of altered signal in the brain parenchyma. Diffuse cortical atrophy was present.</p>
        <p>Single photon emission computed tomography (SPECT) showed widespread hypoperfusion of the cerebral cortex, with thinning of cortical thickness. The hypoperfusion of both hemispheres appeared more pronounced in the posterior temporal cortex, with a prevalence in the left hemisphere. Perfusion of the basal ganglia and cerebellar hemispheres was preserved.</p>
        <p>The patient was assessed by the same neuropsychologist for all follow-ups, using a wide battery of neuropsychological tests to investigate all cognitive functions.</p>
      </sec>
      <sec>
        <title>Tests</title>
        <p>Global cognitive impairment was evaluated using Mini&#x2013;Mental State Examination (MMSE).<xref rid="b18-cia-9-031" ref-type="bibr">18</xref> This is a screening test for mental deterioration, assessing the following five areas: orientation to time (score 0&#x2013;5) and place (score 0&#x2013;5); immediate recall, ie, short-term verbal memory (score 0&#x2013;3); attention and calculation (score 0&#x2013;5); delayed recall (score 0&#x2013;3), language (in the sections: naming, verbal fluency, comprehension, reading, and writing) (score 0&#x2013;6); and constructional ability (score 0&#x2013;3). The possible maximum total score is 30. A score of 24 or more in this test is considered diagnostic of normal cognitive status. The MMSE score must be corrected for age and education, in this case, according to procedures standardized for the Italian population.<xref rid="b19-cia-9-031" ref-type="bibr">19</xref></p>
        <sec>
          <title>Mental Deterioration Battery</title>
          <p>The Mental Deterioration Battery (MDB)<xref rid="b20-cia-9-031" ref-type="bibr">20</xref> is a standardized neuropsychological test battery of seven tests used to obtain eight performance scores, four for the elaboration of verbal stimuli and four for the elaboration of visuospatial material. The tests investigate different cognitive areas: language (Phonological Verbal Fluency<xref rid="b21-cia-9-031" ref-type="bibr">21</xref>; Sentence Construction<xref rid="b22-cia-9-031" ref-type="bibr">22</xref>), verbal memory (Rey&#x2019;s 15-word Immediate and Delayed Recall<xref rid="b23-cia-9-031" ref-type="bibr">23</xref>), visual memory (Immediate Visual Memory<xref rid="b24-cia-9-031" ref-type="bibr">24</xref>), logical reasoning (Raven&#x2019;s Progressive Matrices<xref rid="b25-cia-9-031" ref-type="bibr">25</xref>), and constructional praxis (Copying Drawing and Landmark Drawing Copy Test<xref rid="b26-cia-9-031" ref-type="bibr">26</xref>).</p>
          <p>Individual performance can range between 0 and 8, according to the number of test scores above the cutoff; a score of below 4 characterizes demented subjects.</p>
          <p>We added other cognitive tests to this test battery, with the aim of obtaining a more complete and exhaustive neuropsychological profile assessing all cognitive functions (memory, language, attention, and executive functions).</p>
        </sec>
        <sec>
          <title>Memory</title>
          <p>Three additional tests were administered in order to assess memory functions more comprehensively: the Corsi block-tapping test<xref rid="b27-cia-9-031" ref-type="bibr">27</xref> and digit span test,<xref rid="b28-cia-9-031" ref-type="bibr">28</xref> respectively, for visuospatial and verbal short-term memory, and the story recall test<xref rid="b27-cia-9-031" ref-type="bibr">27</xref> for the evaluation of episodic memory.</p>
        </sec>
        <sec>
          <title>Language</title>
          <p>To assess language functioning, we used the Aachener Aphasie Test,<xref rid="b29-cia-9-031" ref-type="bibr">29</xref> comprising six subtests: spontaneous speech, token test, repetition, written language, naming, and comprehension; and a semantic verbal fluency test.<xref rid="b27-cia-9-031" ref-type="bibr">27</xref></p>
        </sec>
        <sec>
          <title>Attention</title>
          <p>To assess attention deficits we used the Alertness test from the German Testbatterie zur Aufmerksamkeitsprufung or Test for Attentional Performance (TAP).<xref rid="b30-cia-9-031" ref-type="bibr">30</xref></p>
          <p>This test measures reaction time (RT) with or without a warning signal (tone). In the test, a cross appears in the middle of the computer screen, and the subject has to press a button as rapidly as possible. The order of block presentation is ABBA, in which A is the block without a tone and B is the block with a warning signal. A total of 80 trials were presented. The three parameters evaluated are: reaction times, number of omissions, and the index of phasic alertness.</p>
        </sec>
        <sec>
          <title>Executive functions</title>
          <p>We assessed various aspects of executive abilities, such as shifting, interference inhibition, reasoning, and planning.</p>
          <p>The Trail Making Test (TMT)<xref rid="b31-cia-9-031" ref-type="bibr">31</xref> was used to explore visual&#x2013;conceptual and visual&#x2013;motor tracking.</p>
          <p>The Stroop test<xref rid="b32-cia-9-031" ref-type="bibr">32</xref> measured the ability to control and inhibit the automatic response.</p>
        </sec>
        <sec>
          <title>Depression assessment</title>
          <p>We used a short version (15 items) of the Geriatric Depression Scale (GDS)<xref rid="b33-cia-9-031" ref-type="bibr">33</xref> to evaluate the possible presence of depression. The GDS questions are answered by stating &#x201C;yes&#x201D; or &#x201C;no.&#x201D; This simplicity enables the scale to be used with individuals who are ill or moderately cognitively impaired. A score higher than 5 is indicative of depression.</p>
        </sec>
        <sec>
          <title>Psychiatric evaluation</title>
          <p>Neuropsychiatric symptoms were evaluated using the Neuropsychiatric Inventory (NPI).<xref rid="b34-cia-9-031" ref-type="bibr">34</xref> Twelve behavioral domains are evaluated in this test: delusions, hallucinations, agitation/aggression, dysphoria, anxiety, euphoria, apathy, disinhibition, irritability/lability, aberrant motor activity, nighttime behavioral disturbances, and appetite/eating disorders.</p>
          <p>The NPI is comprised of screening questions used to ask the caregiver whether the patient&#x2019;s behavior has changed since the onset of dementia and if so, whether the altered behavior was present during the last month.</p>
          <p>The Italian version of the NPI was validated by Binetti et al<xref rid="b35-cia-9-031" ref-type="bibr">35</xref> in Alzheimer&#x2019;s disease patients and has demonstrated comparable psychometric properties.</p>
        </sec>
        <sec>
          <title>Functional assessment</title>
          <p>Functional autonomy was evaluated using the basic Activities of Daily Living (ADL) scale<xref rid="b36-cia-9-031" ref-type="bibr">36</xref> and the Instrumental Activities of Daily Living (IADL) scale.<xref rid="b37-cia-9-031" ref-type="bibr">37</xref> These are two indices of functional dependence; the ADL scale measures the patient&#x2019;s abilities in basic self-care tasks, such as feeding, bathing, walking and transferring, maintaining continence, etc; whereas the IADL scale explores instrumental activities, including telephoning, outdoor mobility and grocery shopping, travelling, taking medicines, managing money, housekeeping, preparing meals, and laundry.</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p><xref ref-type="table" rid="t1-cia-9-031">Tables 1</xref>&#x2013;<xref ref-type="table" rid="t4-cia-9-031">4</xref> summarize the patient data for each test. The patient&#x2019;s score and the cutoff in the standardization sample for each test are shown. For the attention test of the TAP battery, the medians of reaction times are shown.</p>
      <p>At diagnosis, the patient showed a severe depression of mood state, with dysarthric language and an impairment of cognitive functioning characterized by memory deficits, reduced phonemic and semantic fluency, and deficits in abstract reasoning. The reaction times were mildly slow.</p>
      <p>Neurologically, gait ataxic disturbances, balance deficits, and supranuclear upgaze paresis were already present. No falls were reported.</p>
      <p>As regards behavioral symptoms, an interview with relatives revealed depression, anxiety, apathy, irritability, and sleep disorders.</p>
      <p>As to functional independence, the patient was autonomous in activities of daily living, such as basic self-care tasks but needed help with instrumental activities.</p>
      <p>After the evaluation the patient began pharmacological treatment with rivastigmine 6 mg daily for 6 months and paroxetine 20 mg daily.</p>
      <p>At the first follow-up visit, after 6 months from diagnosis, he showed a further impairment of cognitive deficits and of balance disturbances, with bradykinesia. The patient appeared to relatives to be less anxious, depressed, and apathetic but also more dependent on others for simple daily living activities, such as feeding and bathing. However, the patient himself complained of sadness and depression, although he still showed interest in his life.</p>
      <p>The patient&#x2019;s relatives reported the onset of great difficulty in his building management, a task that he had previously carried out without any problems.</p>
      <p>A further SPECT showed widespread hypoperfusion of the cerebral cortex, with thinning of the cortical thickness. The hypoperfusion of both hemispheres in the frontal and temporal cortexes appeared more pronounced than earlier. Perfusion of the basal ganglia and cerebellar hemispheres was preserved.</p>
      <p>The results of neuropsychological evaluation showed a further worsening of cognitive performance, above all of memory, attention, and language, with the patient demonstrating anomia, and semantic and verbal paraphasic errors.</p>
      <p>The language examination using Aachener Aphasie Test (AAT) showed, at that time, a mild nonfluent, Broca-like aphasia with language deficits, which were most evident in expression and were characterized by word retrieval difficulties and anomia, and some semantic paraphasias. His conversational/narrative speech was characterized by a slow speech rate, prolonged intervals between syllables and words, and decreased articulatory accuracy with increased speaking rate. These are all characteristics of AOS. His prosody was also abnormal. He also displayed word repetition, characterized by phonemic substitution; his comprehension was better than expression, but the patient had more difficulty with the syntactically complex sentences. He printed dictated words and sentences adequately, such as words and phrases read aloud.</p>
      <p>The early clinical and neuropsychological manifestations in this case were consistent with PSP syndrome, even if the neuroradiological data were unusual in regard to the usual involvement of the subcortical gray and brainstem region reported in the literature.</p>
      <p>It was decided to change the pharmacological therapy, substituting paroxetine with 50 mg of sertraline, daily. Sertraline hydrochloride is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class and is also a dopamine reuptake inhibitor. Moreover, a combination of melevodopa (l-dopa methylester, a highly soluble prodrug of l-dopa) plus carbidopa in an effervescent tablet formulation (CHF 1512; Sirio Pharma Co, Ltd, Shantou, People&#x2019;s Republic of China) and zolpidem, a nonbenzodiazepine hypnotic drug (with an imidazopyridine structure that binds to the GABA-benzodiazepine receptor complex found in high density in basal ganglia), were prescribed.</p>
      <p>After 6 months, a new multidimensional evaluation showed a rather stable situation, both in cognitive and functional aspects. The pharmacological therapy with rivastigmine, sertraline, levodopa, and zolpidem was confirmed.</p>
      <p>The onset of a spastic smile and psychomotor slowing led to the patient requesting a return visit. The assessment identified an impairment of the patient&#x2019;s functional autonomy, both in simple and instrumental daily activities, and in executive functions, as demonstrated by the phonological and semantic verbal fluency tests and the patient&#x2019;s inability to perform the TMT and the Stroop Test. A new drug, memantine, at a daily dose of 20 mg, was added to the therapy.</p>
      <p>After 6 months of treatment with memantine, the neuropsychiatric symptomatology was reduced in our patient, although moderate depression and mild irritability continued. As regards cognitive functions, the patient&#x2019;s spontaneous speech had become poor, telegraphic, and echolalic; compared with the previous language assessment, we observed a further impairment of sentence comprehension and repetition, with more severe difficulty with phrases and syntagma.</p>
      <p>The patient&#x2019;s wife had noticed a frequent cough when he drank and sometimes during a meal. A videofluoroscopic examination showed moderate dysphagia.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>A spectrum of clinical syndromes and neurodegenerative disorders must be considered in a patient who presents with these neuropsychological and clinical symptoms. Frontotemporal dementia, progressive nonfluent aphasia, and corticobasal degeneration (CBD) all represent syndromes reflecting asymmetric cortical dysfunction.<xref rid="b38-cia-9-031" ref-type="bibr">38</xref> PSP has been associated with CBD syndrome.<xref rid="b39-cia-9-031" ref-type="bibr">39</xref> Dementia with Lewy bodies rarely presents as an asymmetrical cortical degeneration syndrome.<xref rid="b40-cia-9-031" ref-type="bibr">40</xref></p>
      <p>We tested a wide range of cognitive functions in this patient and the response of his disease to all the drugs available for this pathology.</p>
      <p>The early clinical and neuropsychological manifestations were the most consistent with PSP syndrome. He exhibited gait impairment and supranuclear gaze palsy, typical of PSP. The overlap of PSP with CBD has been increasingly recognized lately. Our patient did not present limb apraxia, asymmetric extrapyramidal syndrome, alien limb behavior, myoclonus, or cortical sensory loss, all typical findings of CBD.</p>
      <p>Our patient showed depression of mood state as the first symptom of the pathology. Moreover, this was resistant to all pharmacological treatment as the patient continued to be depressed at all follow-up visits, as shown by the GDS scores.</p>
      <p>Most published reports<xref rid="b41-cia-9-031" ref-type="bibr">41</xref>,<xref rid="b42-cia-9-031" ref-type="bibr">42</xref> on behavior in PSP patients have been single case studies and have emphasized symptoms related to depression, psychosis, or obsessive features. Borroni et al,<xref rid="b8-cia-9-031" ref-type="bibr">8</xref> in a sample of 24 PSP patients, found a high frequency of depression, anxiety, sleep, and eating disorders. More recently, Fukui et al<xref rid="b42-cia-9-031" ref-type="bibr">42</xref> studied 74 PSP patients, observing a relatively high incidence (24%) of obsessive&#x2013;compulsive symptoms. These are frequent but under recognized neuropsychiatric symptoms of dementia in PSP, probably due to a dysfunction of the fronto&#x2013;caudate&#x2013; thalamus&#x2013;cerebellum circuit.</p>
      <p>Unlike the results of Litvan et al,<xref rid="b15-cia-9-031" ref-type="bibr">15</xref> which indicated apathy as the dominant behavioral change in PSP, the main behavioral symptom in our case was depression. The apathy that the patient showed in the early stage of disease was replaced by an unmistakable depression.</p>
      <p>Depressive symptoms can appear as an initial manifestation of an incipient cognitive change or can be interpreted as a risk factor for cognitive decline, or can be a concomitant disease, possibly the result of an awareness of cognitive difficulties, as suggested by previous authors.<xref rid="b43-cia-9-031" ref-type="bibr">43</xref>,<xref rid="b44-cia-9-031" ref-type="bibr">44</xref></p>
      <p>With regard to cognitive functions, only a mild executive deficit was found in the patient at the first neuropsychological examination performed following the onset of the depression.</p>
      <p>Functional imaging studies of PSP patients show a deafferentation of the frontal lobes. The frontal lobes have reduced perfusion despite limited local pathological changes. The metabolic deficits are found in areas disconnected from the prominent subcortical pathology of PSP.</p>
      <p>There are five frontal subcortical circuits, originating in the supplementary motor area, frontal eye fields, dorsolateral prefrontal cortex, orbitofrontal cortex, and anterior cingulated cortex. These circuits unite regions of the frontal lobe with the striatum, globus pallidus, and thalamus in functional systems that mediate motor activities, eye movements, cognition, and behavior. In PSP, all five circuits are impaired.<xref rid="b15-cia-9-031" ref-type="bibr">15</xref>,<xref rid="b45-cia-9-031" ref-type="bibr">45</xref></p>
      <p>MRI of our patient showed no involvement of either the frontal areas or of the subcortical structures. Moreover, the first SPECT imaging performed showed a hypoperfusion in both temporal posterior hemispheres, although moderate depression and mild cognitive symptoms were evident. Only the second SPECT scan showed a reduced perfusion of both frontal lobes.</p>
      <p>As suggested in the literature,<xref rid="b46-cia-9-031" ref-type="bibr">46</xref> there is a worsening of executive functions only in the later stages of disease when the frontal structures are more involved, while the onset of neuropsychiatric disorders are independent of cognitive deficits, due to the dysfunction of different subcortical circuits.</p>
      <p>The peculiarity of our case is the lack of an obvious involvement of subcortical structures, as the MRI and SPECT images showed, even in the phase of disease during which the patient showed obvious motor deficits.</p>
      <p>With regard to neuropsychological characteristics, our results are in accordance with the literature. At the first stage of the disease, our patient showed a mild deficit in verbal phonemic fluency and in long-term memory, and slow reaction times. In fact, one study has reported that letter fluency tends to be more severely affected than category fluency.<xref rid="b47-cia-9-031" ref-type="bibr">47</xref> The short-term memory is considered to be relatively well preserved in PSP.<xref rid="b48-cia-9-031" ref-type="bibr">48</xref> Other authors<xref rid="b49-cia-9-031" ref-type="bibr">49</xref>,<xref rid="b50-cia-9-031" ref-type="bibr">50</xref> have demonstrated the prolonged reaction times and a cognitive slowing independent of the motor function. As to language, repeated studies<xref rid="b12-cia-9-031" ref-type="bibr">12</xref>&#x2013;<xref rid="b14-cia-9-031" ref-type="bibr">14</xref> have demonstrated the nonfluent aphasia in this neurodegenerative disorder, such as an impairment of oral and written comprehension, also found by Podoll et al<xref rid="b51-cia-9-031" ref-type="bibr">51</xref> in five patients with PSP.</p>
      <p>Certainly the disorder of speech and communication in PSP can take different forms. Dysarthria is the most common, but dysprosody, aphonia, stuttering, palilalia, and echolalia, as well as abnormal loquacity have also been described.<xref rid="b52-cia-9-031" ref-type="bibr">52</xref>,<xref rid="b53-cia-9-031" ref-type="bibr">53</xref></p>
      <p>To date, there is no approved treatment for PSP. Treatment with levodopa<xref rid="b54-cia-9-031" ref-type="bibr">54</xref> may alleviate some motor symptoms, such as bradykinesia and rigidity, but only 20%&#x2013;40% of PSP patients respond to it. Levodopa can be combined with other therapies, such as serotonergic drugs, which improve depressive symptoms but which are ineffective in the treatment of cognitive and other symptoms.</p>
      <p>The cholinergic system is impaired in PSP, as evidenced by a decrease in choline acetyltransferase activity in the basal ganglia and by a loss of mesencephalic cholinergic nuclei.<xref rid="b55-cia-9-031" ref-type="bibr">55</xref> This cholinergic deficit may explain the cognitive dysfunction. Donepezil is a centrally acting cholinesterase inhibitor that prolongs the action of acetylcholine in residual cholinergic neurons. Fabbrini et al<xref rid="b55-cia-9-031" ref-type="bibr">55</xref> investigated the efficacy and tolerability of donepezil in six PSP patients and found no significant changes in cognitive deficits or in autonomy in daily living activities.</p>
      <p>In contrast to other cholinesterase inhibitors, rivastigmine inhibits both acetylcholinesterase and butyrylcholinesterase and, in a small number of patients, produces a slight improvement in cognitive symptoms.<xref rid="b16-cia-9-031" ref-type="bibr">16</xref></p>
      <p>In 12 patients with PSP, Foster et al<xref rid="b56-cia-9-031" ref-type="bibr">56</xref> found a loss of interneurons containing benzodiazepine/GABA receptors, primarily in the anterior cingulated cortex, together with a deafferentation of the cerebral cortex from distant brain regions. Treatment with GABA agonists could be useful in PSP patients. Zolpidem is a GABA agonist of the benzodiazepine BZ1 subtype receptor and has been used in a small number of patients with PSP. Cotter et al<xref rid="b5-cia-9-031" ref-type="bibr">5</xref> found a sustained improvement in motor and ocular symptoms in a patient with PSP who was treated with controlled-release zolpidem over a period of 6 months.</p>
      <p>Memantine is a new medication that acts on the glutamatergic system by blocking the N-methyl-D-aspartate (NMDA)-type glutamate receptors.</p>
      <p>This medicine is used for the treatment of moderate to severe dementia of the Alzheimer type. Recent evidence<xref rid="b57-cia-9-031" ref-type="bibr">57</xref>,<xref rid="b58-cia-9-031" ref-type="bibr">58</xref> has suggested that memantine is safe and might confer some cognitive improvement for individuals with dementia in Parkinson&#x2019;s disease and dementia with Lewy bodies. There are no studies on memantine treatment in patients with PSP.</p>
      <p>Recently, Gold et al<xref rid="b1-cia-9-031" ref-type="bibr">1</xref> investigated the use of davunetide, an advanced product in PSP. This is a novel neuroprotective peptide that is thought to impact neuronal integrity and cell survival through the stabilization of microtubules.</p>
      <p>The studies on the efficacy and tolerability of pharmacological treatments in PSP patients have not provided any positive results. Our data also confirmed the inefficacy of available drugs, even in combination. Perhaps the aspect of associations between various therapies was not considered in the literature. This is a further point provided by our case. However, we investigated the efficacy of memantine in our patient with PSP and concluded that there was no significant slowing of disease progression, probably due to the stage of pathology.</p>
      <p>A limitation of this study is that it involved a single case, and there was no control group. Moreover, we did not confirm the diagnosis, considering the lack of neuropathological findings. This weakness did not allow the achievement of any statistically significant data.</p>
      <p>It could be interesting to investigate the use of memantine in a large group of patients and in the early stages of disease. Future strategies to treat PSP will require larger and prospective studies with multicenter trials.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>In conclusion, in PSP patients, depression can represent a first symptom before an overt onset of disease. Moreover, the lack of involvement of the subcortical structures, as shown with MRI, even when the patient had a severe motor impairment, was an important and particular aspect of our case and is necessary to consider when diagnosing this neurodegenerative disease in other patients.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Disclosure</bold>
        </p>
        <p>The authors report no conflicts of interest in this work.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-cia-9-031">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gold</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lorenzl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Morimoto</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Gozes</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy</article-title>
          <source>Neuropsychiatr Dis Treat</source>
          <year>2012</year>
          <volume>8</volume>
          <fpage>85</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">22347799</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-cia-9-031">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schrag</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ben-Shlomo</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>NP</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study</article-title>
          <source>Lancet</source>
          <year>1999</year>
          <volume>354</volume>
          <issue>9192</issue>
          <fpage>1771</fpage>
          <lpage>1775</lpage>
          <pub-id pub-id-type="pmid">10577638</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-cia-9-031">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winter</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bezdolnyy</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Katunina</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence of Parkinson&#x2019;s disease and atypical parkinsonism: Russian population-based study</article-title>
          <source>Mov Disord</source>
          <year>2010</year>
          <volume>25</volume>
          <issue>3</issue>
          <fpage>349</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="pmid">20108378</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-cia-9-031">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Litvan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Agid</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Calne</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop</article-title>
          <source>Neurology</source>
          <year>1996</year>
          <volume>47</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8710059</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-cia-9-031">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cotter</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Armytage</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Crimmins</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The use of zolpidem in the treatment of progressive supranuclear palsy</article-title>
          <source>J Clin Neurosci</source>
          <year>2010</year>
          <volume>17</volume>
          <issue>3</issue>
          <fpage>385</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">20071178</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-cia-9-031">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albert</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Willis</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>The &#x201C;subcortical dementia&#x201D; of progressive supranulcear palsy</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1974</year>
          <volume>37</volume>
          <issue>2</issue>
          <fpage>121</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">4819905</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-cia-9-031">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cummings</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology</article-title>
          <source>Br J Psychiatry</source>
          <year>1986</year>
          <volume>149</volume>
          <fpage>682</fpage>
          <lpage>697</lpage>
          <pub-id pub-id-type="pmid">2878699</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-cia-9-031">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borroni</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Turla</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bertasi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Agosti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gilberti</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Padovani</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes</article-title>
          <source>Arch Gerontol Geriatr</source>
          <year>2008</year>
          <volume>47</volume>
          <issue>1</issue>
          <fpage>53</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">17765337</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-cia-9-031">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kertesz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McMonagle</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy</article-title>
          <source>J Neurol Sci</source>
          <year>2010</year>
          <volume>289</volume>
          <issue>1&#x2013;2</issue>
          <fpage>138</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">19733862</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-cia-9-031">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bak</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Hodges</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>The neuropsychology of progressive supranuclear palsy</article-title>
          <source>Neurocase</source>
          <year>1998</year>
          <volume>4</volume>
          <issue>2</issue>
          <fpage>89</fpage>
          <lpage>94</lpage>
        </element-citation>
      </ref>
      <ref id="b11-cia-9-031">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soliveri</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Monza</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Paridi</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuropsychological follow up in patients with Parkinson&#x2019;s disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2000</year>
          <volume>69</volume>
          <issue>3</issue>
          <fpage>313</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">10945805</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-cia-9-031">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boeve</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dickson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Duffy</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bartleson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Trenerry</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology</article-title>
          <source>Eur Neurol</source>
          <year>2003</year>
          <volume>49</volume>
          <issue>2</issue>
          <fpage>72</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">12584413</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-cia-9-031">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joseph</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Boeve</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Duffy</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia</article-title>
          <source>Neurocase</source>
          <year>2005</year>
          <volume>11</volume>
          <issue>4</issue>
          <fpage>283</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">16093229</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-cia-9-031">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Josephs</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Duffy</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy</article-title>
          <source>Curr Opin Neurol</source>
          <year>2008</year>
          <volume>21</volume>
          <issue>6</issue>
          <fpage>688</fpage>
          <lpage>692</lpage>
          <pub-id pub-id-type="pmid">18989114</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-cia-9-031">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Litvan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mega</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Fairbanks</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Neuropsychiatric aspects of progressive supranuclear palsy</article-title>
          <source>Neurology</source>
          <year>1996</year>
          <volume>47</volume>
          <issue>5</issue>
          <fpage>1184</fpage>
          <lpage>1189</lpage>
          <pub-id pub-id-type="pmid">8909427</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-cia-9-031">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liepelt</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gaenslen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Godau</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis</article-title>
          <source>Alzheimers Dement</source>
          <year>2010</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>70</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">20129321</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-cia-9-031">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dubois</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Slachevsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Litvan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pillon</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>The FAB: a Frontal Assessment Battery at bedside</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <volume>55</volume>
          <issue>11</issue>
          <fpage>1621</fpage>
          <lpage>1626</lpage>
          <pub-id pub-id-type="pmid">11113214</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-cia-9-031">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Folstein</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Folstein</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>McHugh</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>&#x201C;Mini-mental state&#x201D;. A practical method for grading the cognitive state of patients for the clinician</article-title>
          <source>J Psychiatr Res</source>
          <year>1975</year>
          <volume>12</volume>
          <issue>3</issue>
          <fpage>189</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="pmid">1202204</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-cia-9-031">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Measso</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cavarzeran</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zappal&#xE0;</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The mini-mental state examination: Normative study of an Italian random sample</article-title>
          <source>Develop Neuropsychol</source>
          <year>1993</year>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>77</fpage>
          <lpage>85</lpage>
        </element-citation>
      </ref>
      <ref id="b20-cia-9-031">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlesimo</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Caltagirone</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gainotti</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery</article-title>
          <source>Eur Neurol</source>
          <year>1996</year>
          <volume>36</volume>
          <fpage>378</fpage>
          <lpage>384</lpage>
          <pub-id pub-id-type="pmid">8954307</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-cia-9-031">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borkowsky</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Benton</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Spreen</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Word fluency and brain-damage</article-title>
          <source>Neuropsychologia</source>
          <year>1967</year>
          <volume>5</volume>
          <fpage>135</fpage>
          <lpage>140</lpage>
        </element-citation>
      </ref>
      <ref id="b22-cia-9-031">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gainotti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Caltagirone</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Miceli</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Sui rapporti fra alcune prove di intelligenza verbale e lesioni focali monoemisferiche</article-title>
          <source>Acta Neurologica</source>
          <year>1976</year>
          <volume>31</volume>
          <fpage>370</fpage>
          <lpage>381</lpage>
          <comment>Italian</comment>
          <pub-id pub-id-type="pmid">1015380</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-cia-9-031">
        <label>23</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Rey</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Memorisation d&#x2019;une serie de 15 mots en 5 repetitions</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Rey</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <source>L&#x2019;examen Clinique en Psychologie</source>
          <publisher-loc>Paris, France</publisher-loc>
          <publisher-name>Presses Universitaires de France</publisher-name>
          <year>1958</year>
        </element-citation>
      </ref>
      <ref id="b24-cia-9-031">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caltagirone</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gainotti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Masullo</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Validity of some neuropsychological tests in assessment of mental deterioration</article-title>
          <source>Acta Psychiatr Scand</source>
          <year>1979</year>
          <volume>60</volume>
          <fpage>50</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">474177</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-cia-9-031">
        <label>25</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Raven</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <source>Progressive Matrices Set A, Ab, B: Board and Book Forms</source>
          <publisher-loc>London, England</publisher-loc>
          <publisher-name>Lewis</publisher-name>
          <year>1947</year>
        </element-citation>
      </ref>
      <ref id="b26-cia-9-031">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gainotti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Miceli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Caltagirone</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Constructional apraxia in left brain-damaged patients: A planning disorder?</article-title>
          <source>Cortex</source>
          <year>1977</year>
          <volume>13</volume>
          <fpage>109</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="pmid">16295955</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-cia-9-031">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spinnler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tognoni</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Standardizzazione e taratura di test neuropsicologici [Italian normative values and standardization of neuropsychological tests]</article-title>
          <source>Ital J Neurol Sci</source>
          <year>1987</year>
          <volume>6</volume>
          <issue>Suppl 8</issue>
          <fpage>S1</fpage>
          <lpage>S120</lpage>
          <comment>Italian</comment>
        </element-citation>
      </ref>
      <ref id="b28-cia-9-031">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orsini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grossi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Capitani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Laiacona</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Papagno</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vallar</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children</article-title>
          <source>Ital J Neurol Sci</source>
          <year>1987</year>
          <volume>8</volume>
          <issue>6</issue>
          <fpage>539</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">3429213</pub-id>
        </element-citation>
      </ref>
      <ref id="b29-cia-9-031">
        <label>29</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Luzzatti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Willmes</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>De Bleser</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <source>L&#x2018;Aachener Aphasie Test (AAT), Versione Italiana. Manuale e Dati Normativi [The Aachener Aphasie Test {AAT}, Italian Version. Manual and Normative Data]</source>
          <edition>2nd ed</edition>
          <publisher-loc>Firenze</publisher-loc>
          <publisher-name>Organizzazione Speciali</publisher-name>
          <year>1996</year>
          <year>Italian</year>
        </element-citation>
      </ref>
      <ref id="b30-cia-9-031">
        <label>30</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fimm</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <source>Testbatterie zur Aufmerksamkeitsprufung [Tests of Attentional Performance{TAP}]</source>
          <publisher-loc>Wurselen</publisher-loc>
          <publisher-name>Psytest</publisher-name>
          <year>1992</year>
          <comment>German</comment>
        </element-citation>
      </ref>
      <ref id="b31-cia-9-031">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giovagnoli</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Del Pesce</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mascheroni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Simoncelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Laiacona</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Capitani</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Trail making test: normative values from 287 normal adult controls</article-title>
          <source>Ital J Neurol Sci</source>
          <year>1996</year>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>305</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="pmid">8915764</pub-id>
        </element-citation>
      </ref>
      <ref id="b32-cia-9-031">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caffarra</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vezzadini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dieci</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zonato</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Venneri</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Una versione abbreviata del test di Stroop: dati normativi nella popolazione italiana [An abbreviated version of the Stroop Test: normative data in the Italian population]</article-title>
          <source>Rivista di Neurologia</source>
          <year>2002</year>
          <volume>12</volume>
          <issue>4</issue>
          <fpage>111</fpage>
          <lpage>115</lpage>
          <comment>Italian</comment>
        </element-citation>
      </ref>
      <ref id="b33-cia-9-031">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yesavage</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Geriatric Depression Scale</article-title>
          <source>Psychopharmacol Bull</source>
          <year>1988</year>
          <volume>24</volume>
          <issue>4</issue>
          <fpage>709</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="pmid">3249773</pub-id>
        </element-citation>
      </ref>
      <ref id="b34-cia-9-031">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cummings</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Mega</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rosenberg-Thompson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carusi</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Gornbein</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia</article-title>
          <source>Neurology</source>
          <year>1994</year>
          <volume>44</volume>
          <issue>12</issue>
          <fpage>2308</fpage>
          <lpage>2314</lpage>
          <pub-id pub-id-type="pmid">7991117</pub-id>
        </element-citation>
      </ref>
      <ref id="b35-cia-9-031">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Binetti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mega</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Magni</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Behavioral disorders in Alzheimer&#x2019;s disease: a transcultural perspective</article-title>
          <source>Arch Neurol</source>
          <year>1998</year>
          <volume>55</volume>
          <issue>4</issue>
          <fpage>539</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="pmid">9561983</pub-id>
        </element-citation>
      </ref>
      <ref id="b36-cia-9-031">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ford</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Moskowitz</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function</article-title>
          <source>JAMA</source>
          <year>1963</year>
          <volume>185</volume>
          <fpage>914</fpage>
          <lpage>919</lpage>
          <pub-id pub-id-type="pmid">14044222</pub-id>
        </element-citation>
      </ref>
      <ref id="b37-cia-9-031">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawton</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Brody</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Assessment of older people: self-maintaining and instrumental activities of daily living</article-title>
          <source>Gerontologist</source>
          <year>1969</year>
          <volume>9</volume>
          <issue>3</issue>
          <fpage>179</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="pmid">5349366</pub-id>
        </element-citation>
      </ref>
      <ref id="b38-cia-9-031">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feldman</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>McKee</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 46&#x2013;1993. A 75-year-old man with right-sided rigidity, dysarthria, and abnormal gait</article-title>
          <source>N Engl J Med</source>
          <year>1993</year>
          <volume>329</volume>
          <issue>21</issue>
          <fpage>1560</fpage>
          <lpage>1567</lpage>
          <pub-id pub-id-type="pmid">8413479</pub-id>
        </element-citation>
      </ref>
      <ref id="b39-cia-9-031">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadler</surname>
              <given-names>JZ</given-names>
            </name>
            <name>
              <surname>Kurtz</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Rush</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Progressive supranuclear palsy presenting as pseudodementia</article-title>
          <source>Psychosomatics</source>
          <year>1984</year>
          <volume>25</volume>
          <issue>9</issue>
          <fpage>713</fpage>
          <lpage>714</lpage>
          <pub-id pub-id-type="pmid">6494408</pub-id>
        </element-citation>
      </ref>
      <ref id="b40-cia-9-031">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caselli</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Focal and asymmetric cortical degeneration syndromes</article-title>
          <source>The Neurologist</source>
          <year>1995</year>
          <volume>1</volume>
          <fpage>1</fpage>
          <lpage>19</lpage>
        </element-citation>
      </ref>
      <ref id="b41-cia-9-031">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Chui</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Progressive supranuclear palsy manifesting with depressive features</article-title>
          <source>J Am Geriatr Soc</source>
          <year>1986</year>
          <volume>34</volume>
          <issue>9</issue>
          <fpage>663</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="pmid">3734316</pub-id>
        </element-citation>
      </ref>
      <ref id="b42-cia-9-031">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fukui</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hosoda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okita</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Obsessive-compulsive behavior as a symptom of dementia in progressive supranuclear palsy</article-title>
          <source>Dement Geriatr Cogn Disord</source>
          <year>2010</year>
          <volume>30</volume>
          <issue>2</issue>
          <fpage>179</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">20798538</pub-id>
        </element-citation>
      </ref>
      <ref id="b43-cia-9-031">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Mendes de Leon</surname>
              <given-names>CF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Depressive symptoms, cognitive decline, and risk of AD in older persons</article-title>
          <source>Neurology</source>
          <year>2002</year>
          <volume>59</volume>
          <issue>3</issue>
          <fpage>364</fpage>
          <lpage>370</lpage>
          <pub-id pub-id-type="pmid">12177369</pub-id>
        </element-citation>
      </ref>
      <ref id="b44-cia-9-031">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bassuk</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Berkman</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Wypij</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Depressive symptomatology and incident cognitive decline in an elderly community sample</article-title>
          <source>Arch Gen Psychiatry</source>
          <year>1998</year>
          <volume>55</volume>
          <issue>12</issue>
          <fpage>1073</fpage>
          <lpage>1081</lpage>
          <pub-id pub-id-type="pmid">9862549</pub-id>
        </element-citation>
      </ref>
      <ref id="b45-cia-9-031">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Horwitz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Agid</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Does frontal cortex hypometabolism in progressive supranuclear palsy result from subcortical dysfunction?</article-title>
          <source>Eur J Neurol</source>
          <year>1995</year>
          <volume>1</volume>
          <issue>3</issue>
          <fpage>221</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">24283522</pub-id>
        </element-citation>
      </ref>
      <ref id="b46-cia-9-031">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pillon</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dubois</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Agid</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Severity and specificity of cognitive impairment in Alzheimer&#x2019;s, Huntington&#x2019;s, and Parkinson&#x2019;s diseases and progressive supranuclear palsy</article-title>
          <source>Neurology</source>
          <year>1991</year>
          <volume>41</volume>
          <fpage>634</fpage>
          <lpage>643</lpage>
          <pub-id pub-id-type="pmid">1827513</pub-id>
        </element-citation>
      </ref>
      <ref id="b47-cia-9-031">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosser</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hodges</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Initial letter and semantic category fluency in Alzheimer&#x2019;s disease, Huntington&#x2019;s disease, and progressive supranuclear palsy</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1994</year>
          <volume>57</volume>
          <issue>11</issue>
          <fpage>1389</fpage>
          <lpage>1394</lpage>
          <pub-id pub-id-type="pmid">7964817</pub-id>
        </element-citation>
      </ref>
      <ref id="b48-cia-9-031">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Litvan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Grafman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chase</surname>
              <given-names>TN</given-names>
            </name>
          </person-group>
          <article-title>Memory impairment in patients with progressive supranuclear palsy</article-title>
          <source>Arch Neurol</source>
          <year>1989</year>
          <volume>46</volume>
          <issue>7</issue>
          <fpage>765</fpage>
          <lpage>767</lpage>
          <pub-id pub-id-type="pmid">2742547</pub-id>
        </element-citation>
      </ref>
      <ref id="b49-cia-9-031">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dubois</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pillon</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Legault</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Agid</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lhermitte</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson&#x2019;s disease</article-title>
          <source>Arch Neurol</source>
          <year>1988</year>
          <volume>45</volume>
          <issue>11</issue>
          <fpage>1194</fpage>
          <lpage>1199</lpage>
          <pub-id pub-id-type="pmid">3190499</pub-id>
        </element-citation>
      </ref>
      <ref id="b50-cia-9-031">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grafman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Litvan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Stark</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Neuropsychological features of progressive supranuclear palsy</article-title>
          <source>Brain Cogn</source>
          <year>1995</year>
          <volume>28</volume>
          <issue>3</issue>
          <fpage>311</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">8546857</pub-id>
        </element-citation>
      </ref>
      <ref id="b51-cia-9-031">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Podoll</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schwarz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Noth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Language functions in progressive supranuclear palsy</article-title>
          <source>Brain</source>
          <year>1991</year>
          <volume>114</volume>
          <issue>Pt 3</issue>
          <fpage>1457</fpage>
          <lpage>1472</lpage>
          <pub-id pub-id-type="pmid">2065260</pub-id>
        </element-citation>
      </ref>
      <ref id="b52-cia-9-031">
        <label>52</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Pillon</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dubois</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Cognitive and behavioral impairments</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Litvan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Agid</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <source>Progressive Supranuclear Palsy: Clinical and Research Approaches</source>
          <publisher-loc>New York, NY</publisher-loc>
          <publisher-name>Oxford University Press</publisher-name>
          <year>1992</year>
          <fpage>223</fpage>
          <lpage>239</lpage>
        </element-citation>
      </ref>
      <ref id="b53-cia-9-031">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Della Sala</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Spinnler</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Echolalia in a case of progressive supranuclear palsy</article-title>
          <source>Neurocase</source>
          <year>1998</year>
          <volume>4</volume>
          <fpage>155</fpage>
          <lpage>165</lpage>
        </element-citation>
      </ref>
      <ref id="b54-cia-9-031">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lang</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Treatment of progressive supranuclear palsy and corticobasal degeneration</article-title>
          <source>Mov Disord</source>
          <year>2005</year>
          <issue>Suppl 12</issue>
          <fpage>S83</fpage>
          <lpage>S91</lpage>
          <pub-id pub-id-type="pmid">16092096</pub-id>
        </element-citation>
      </ref>
      <ref id="b55-cia-9-031">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fabbrini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Barbanti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bonifati</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Donepezil in the treatment of progressive supranuclear palsy</article-title>
          <source>Acta Neurol Scand</source>
          <year>2001</year>
          <volume>103</volume>
          <issue>2</issue>
          <fpage>123</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="pmid">11227131</pub-id>
        </element-citation>
      </ref>
      <ref id="b56-cia-9-031">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foster</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Minoshima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Johanns</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PET measures of benzodiazepine receptors in progressive supranuclear palsy</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <volume>54</volume>
          <issue>9</issue>
          <fpage>1768</fpage>
          <lpage>1773</lpage>
          <pub-id pub-id-type="pmid">10802782</pub-id>
        </element-citation>
      </ref>
      <ref id="b57-cia-9-031">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aarsland</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ballard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Memantine in patients with Parkinson&#x2019;s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial</article-title>
          <source>Lancet Neurol</source>
          <year>2009</year>
          <volume>8</volume>
          <issue>7</issue>
          <fpage>613</fpage>
          <lpage>618</lpage>
          <pub-id pub-id-type="pmid">19520613</pub-id>
        </element-citation>
      </ref>
      <ref id="b58-cia-9-031">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boxer</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lipton</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Womack</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration</article-title>
          <source>Alzheimer Dis Assoc Disord</source>
          <year>2009</year>
          <volume>23</volume>
          <issue>3</issue>
          <fpage>211</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="pmid">19812461</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <table-wrap id="t1-cia-9-031" position="float">
      <label>Table 1</label>
      <caption>
        <p>The patient&#x2019;s scores and cutoff score of the cognitive tests</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1">Test</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Diagnosis</th>
            <th align="left" valign="top" rowspan="1" colspan="1">1 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">2 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">3 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">4 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Cutoff score</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">MMSE</td>
            <td align="left" valign="top" rowspan="1" colspan="1">17.7<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">18.7<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">22.7<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">24.7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18.7<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;24</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">GDS</td>
            <td align="left" valign="top" rowspan="1" colspan="1">14<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">15<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">15<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">15<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">15<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;5</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">ADL</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0/6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3/6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3/6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4/6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5/6</td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">IADL</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4/5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4/5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4/5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5/5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5/5</td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">NPI</td>
            <td align="left" valign="top" rowspan="1" colspan="1">25</td>
            <td align="left" valign="top" rowspan="1" colspan="1">13</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18</td>
            <td align="left" valign="top" rowspan="1" colspan="1">12</td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td colspan="7" align="left" valign="top" rowspan="1">MDB</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Rey&#x2019;s 15-word immediate recall</td>
            <td align="left" valign="top" rowspan="1" colspan="1">21.3<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">14.3<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">20.3<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">16.3<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">16.3<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;28.53</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Rey&#x2019;s 15-word delayed recall</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3.8<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">2.4<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">0<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">2.4<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">1.4<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;4.69</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Immediate visual memory</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18.2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">20.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">17.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;13.85</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Phonological verbal fluency</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2212;1.5<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2212;0.7<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">1.3<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2212;2.7<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.3<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;17.35</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Sentence construction</td>
            <td align="left" valign="top" rowspan="1" colspan="1">15.7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">13.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">13.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;8.72</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Copying drawings</td>
            <td align="left" valign="top" rowspan="1" colspan="1">8.4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">8.6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5.6<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">6.6<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">5.6<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;7.18</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Landmark Drawing Copy test</td>
            <td align="left" valign="top" rowspan="1" colspan="1">66.3</td>
            <td align="left" valign="top" rowspan="1" colspan="1">68.7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">67.7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">59.7<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">64.7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;61.85</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Raven&#x2019;s colored progressive matrices</td>
            <td align="left" valign="top" rowspan="1" colspan="1">15.4<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">11.1<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">10.1<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">11.1<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">15.1<xref ref-type="table-fn" rid="tfn1-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;18.96</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>
            <bold>Note:</bold>
          </p>
        </fn>
        <fn id="tfn1-cia-9-031">
          <label>*</label>
          <p>Pathological score.</p>
        </fn>
        <fn id="tfn2-cia-9-031">
          <p><bold>Abbreviations:</bold> ADL, Activities of Daily Living scale; FU, follow-up; GDS, Geriatric Depression scale; IADL, Instrumental Activities of Daily Living scale; MDB, Mental Deterioration Battery; MMSE, Mini&#x2013;Mental state examination test; NA, not available; NPI, Neuropsychiatric Inventory.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t2-cia-9-031" position="float">
      <label>Table 2</label>
      <caption>
        <p>The patient&#x2019;s scores and cutoff score of the other cognitive tests</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1">Test</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Diagnosis</th>
            <th align="left" valign="top" rowspan="1" colspan="1">1 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">2 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">3 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">4 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Cutoff score</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td colspan="7" align="left" valign="top" rowspan="1">Memory</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Digit span</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3.5<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">3.5<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;3.5</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Visuospatial span</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;3.5</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Prose memory</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">0<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.35<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">0<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td colspan="7" align="left" valign="top" rowspan="1">Language</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Semantic verbal fluency</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3.75<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">2.5<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">3.25<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.75<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">1<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;7</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Naming (AAT)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">7<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">7<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">7<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">6<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;8</td>
          </tr>
          <tr>
            <td colspan="7" align="left" valign="top" rowspan="1">Attention</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Attentive matrices</td>
            <td align="left" valign="top" rowspan="1" colspan="1">34.75</td>
            <td align="left" valign="top" rowspan="1" colspan="1">29.25<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">24.25<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">19.25<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">10.75<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2264;30</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Alertness (RT without warning)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">390<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">406<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">615<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;327</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Alertness (RT with warning)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">379<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">374<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">573<xref ref-type="table-fn" rid="tfn3-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;307</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Phasic index</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.028</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.083</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.070</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2013;</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2013;</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;&#x2212;0.11</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>
            <bold>Note:</bold>
          </p>
        </fn>
        <fn id="tfn3-cia-9-031">
          <label>*</label>
          <p>Pathological score.</p>
        </fn>
        <fn id="tfn4-cia-9-031">
          <p><bold>Abbreviations:</bold> AAT, Aachener Aphasie test; FU, follow-up; NA, not available; RT, reaction time.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t3-cia-9-031" position="float">
      <label>Table 3</label>
      <caption>
        <p>The patient&#x2019;s scores and cutoff score of the executive tests</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1">Test</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Diagnosis</th>
            <th align="left" valign="top" rowspan="1" colspan="1">1 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">2 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">3 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">4 FU</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Cutoff score</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">TMT A</td>
            <td align="left" valign="top" rowspan="1" colspan="1">98<xref ref-type="table-fn" rid="tfn5-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">116<xref ref-type="table-fn" rid="tfn5-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">214<xref ref-type="table-fn" rid="tfn5-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;93</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">TMT B</td>
            <td align="left" valign="top" rowspan="1" colspan="1">230</td>
            <td align="left" valign="top" rowspan="1" colspan="1">225</td>
            <td align="left" valign="top" rowspan="1" colspan="1">284<xref ref-type="table-fn" rid="tfn5-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;282</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">TMT B-A</td>
            <td align="left" valign="top" rowspan="1" colspan="1">132</td>
            <td align="left" valign="top" rowspan="1" colspan="1">110</td>
            <td align="left" valign="top" rowspan="1" colspan="1">71</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;186</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Stroop test (errors)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">1</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.25</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;4.24</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Stroop test (time)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">78.5<xref ref-type="table-fn" rid="tfn5-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">37.25<xref ref-type="table-fn" rid="tfn5-cia-9-031">*</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">32.75</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2265;36.92</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>
            <bold>Note:</bold>
          </p>
        </fn>
        <fn id="tfn5-cia-9-031">
          <label>*</label>
          <p>Pathological score.</p>
        </fn>
        <fn id="tfn6-cia-9-031">
          <p><bold>Abbreviations:</bold> FU, follow-up; NA, not available; TMT, Trail Making test.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t4-cia-9-031" position="float">
      <label>Table 4</label>
      <caption>
        <p>Patient&#x2019;s scores and cutoff score of the language test</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1">Test</th>
            <th align="left" valign="top" rowspan="1" colspan="1">1 evaluation</th>
            <th align="left" valign="top" rowspan="1" colspan="1">2 evaluation</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td colspan="3" align="left" valign="top" rowspan="1">Spontaneous speech</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Communicative behavior</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Articulation and prosody</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Automatic language</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Semantic</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Phonology</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">&#x2003;Syntax</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Token test</td>
            <td align="left" valign="top" rowspan="1" colspan="1">10</td>
            <td align="left" valign="top" rowspan="1" colspan="1">14</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Repetition</td>
            <td align="left" valign="top" rowspan="1" colspan="1">138</td>
            <td align="left" valign="top" rowspan="1" colspan="1">132</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Written language</td>
            <td align="left" valign="top" rowspan="1" colspan="1">89</td>
            <td align="left" valign="top" rowspan="1" colspan="1">84</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Naming</td>
            <td align="left" valign="top" rowspan="1" colspan="1">96</td>
            <td align="left" valign="top" rowspan="1" colspan="1">90</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Comprehension</td>
            <td align="left" valign="top" rowspan="1" colspan="1">103</td>
            <td align="left" valign="top" rowspan="1" colspan="1">85</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
